VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 3433 · 118th Congress

Give Kids a Chance Act of 2024

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Passed the House without a recorded vote, then expired. It passed by voice vote or unanimous consent, which don't record how each member voted, but didn't become law before the 118th Congress ended.

MMR McCaulSponsor
235 cosponsors · 137 D, 98 R
VBR Buchanan DBR Bacon AED Eshoo BFR Fitzpatrick GGR Grothman BHR Huizenga BJR Johnson MKR Kelly YKR Kim JJR (Jim) Moylan DPD Phillips CSR Smith KSD Schrier AKD Kuster JWR Wilson MSR Salazar JND Neguse NLR LaLota DVR Valadao KMD Mullin MWR Waltz CAD Allred MLR Lawler KCD Castor ZLD Lofgren DRD Ross KCR Calvert TCD Cárdenas DKD Kilmer DRR Rouzer DDD Davis NMR Mace BPD Pettersen MGD Gluesenkamp Perez TLD Leger Fernandez YCD Caraveo CPD Pappas JJD Jackson JRR Rutherford BOR Owens JBR Baird TNR Nehls BSD Schneider ASR Smith JVR Van Drew ABR Bean BWR Westerman SBD Brown SCD Cohen SCD Casten MDR De La Cruz AFR Ferguson TKR Kean DLR Lamborn TSD Sewell ESD Slotkin WSR Steube DTD Titus MVD Veasey RYR Yakym RGD Grijalva LGR Gooden AGR Garbarino JHD Harder BLR Luetkemeyer TLD Lieu MMD McGarvey SPD Peters RZR Zinke LBD Blunt Rochester JMD McGovern SMD Moulton RNR Norman JCD Crow JGD Gottheimer DLR LaHood JMD Moskowitz MQD Quigley STD Thanedar ABD Bera MDR Diaz-Balart ASR Scott ESD Swalwell RAR Aderholt NND (Nikki) Budzinski BCR Cline BFR Finstad KGR Granger JTD Tokuda NVD Velázquez ZZR (Zach) Nunn PTD Tonko DTD Trone DWD Wasserman Schultz JCR Carl VFD Foushee CHD Houlahan WKD Keating DMD Matsui CMR Miller LTD Trahan MCR Carey BDR Donalds CFR Fleischmann WND Nickel GTR Thompson BWD Watson Coleman SCD Cherfilus-McCormick GID Ivey GND Napolitano GSD Sablan MWD Waters JCD Correa CDD Deluzio MGR Garcia DGD Goldman SLD Lynch JRD Raskin JLD Larson JAR Arrington JBD Brownley SDD DelBene LFD Fletcher JPD Panetta PSR Sessions MAR Amodei ADR D'Esposito CFR Franklin DLR LaMalfa JCD Costa SJD Jacobs SGR Graves GMD Meng SWD Wild END Norton MDD DeSaulnier AKD Kim TBR Burchett YCD Clarke DDD Dingell DKD Kildee RKD Khanna SLD Lee NMR Malliotakis CMR Mills CPD Pingree ASD Spanberger MSD Stansbury MTD Takano SBR Bice JCD Castro JJD Jackson TKR Kelly TMR Mann AMR Mooney DSD Soto MSD Scanlon LBR Bucshon ACD Craig KPD Porter HCD Cuellar TCD Carter RRD Ruiz MFR Flood JHD Hayes ACR Clyde PJD Jayapal JLR LaTurner SKD Kamlager-Dove JLR Letlow MPD Pocan MSD Strickland MSD Sherrill JWD Wexton JKR Kiggans NBD Barragán CHR Higgins JCD Crockett ESD Sorensen MAR Alford JCR Ciscomani KKR Kiley LSR Smucker JJR James PMR McHenry ESR Stefanik MMR Miller RMR McCormick SDD Davids DHR Harshbarger DMR Meuser BWR Williams RKD Krishnamoorthi JMD Morelle BPR Posey CTR Tenney CBD Bush SDR DesJarlais VGD Gonzalez CGR Gimenez AHR Hinson DSR Schweikert RWR Weber BBD Boyle RJR Jackson MMR Miller NWD Williams DDD DeGette RGD Garcia ALR Luna SCD Carbajal TSD Suozzi BTD Thompson SBD Bonamici JGD Garamendi MKD Kaptur BMD McCollum ECD Cleaver AED Espaillat SJD Jackson Lee GMD Moore JND Nadler JBD Beatty CGD García JSD Sarbanes ASD Salinas DND Norcross BLD Lee JMD McClellan GBR Bilirakis DED Evans JSD Schakowsky HSD Scholten MLD Levin RWR Wittman

13 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

  1. House Introduced May 17, 2023
  2. House Passed Sep 23, 2024

This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer.

What it does: CRS summary · Introduced in House · May 17, 2023

Give Kids a Chance Act of 2023

This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer.

Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations so as to authorize investigations of new drugs that are used in combination with active ingredients that have already been approved and that (1) have been determined to be the standard of care for treating a pediatric cancer, or (2) have been approved to treat an adult cancer and are directed at molecular targets for pediatric cancer.

The Food and Drug Administration must issue guidance and report on the bill's implementation. The Government Accountability Office must report on the effectiveness of the bill's changes with respect to the development of pediatric cancer drugs.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Give Kids a Chance Act of 2024

Also known as: Give Kids a Chance Act of 2023

Latest action (Sep 24, 2024): Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Policy area: Health · Origin: House · Introduced: May 17, 2023

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

  1. House Introduced May 17, 2023
  2. House Passed Sep 23, 2024

No recorded floor vote found.